SHL Telemedicine

SWX:SHLTN · IL0010855885

Health Care Providers & ServicesX-Small

360

Medium confidence — indicative

Value57

Profit price64

Cash yield1

Owner Earnings Yield1

Dividend Yield1

Sales & asset price85

Price/Sales89

EV / Gross Profit93

Price/Book74

Quality35

Returns on capital12

Return on Capital12

Cash Return on Capital10

Return on Equity14

Profit margins33

EBIT Margin12

Gross Profitability53

Cash backing50

Accruals89

Owner Earnings Margin10

Growth—

Sales growth47

Profit growth12

Reinvestment37

Price momentum29

Safety24

Debt load66

Debt serviceability1

Refinancing1

Debt Payback1

Liquidity30

Sentiment56

Analyst ratings—

Expectations trend—

Market mood42

Value Creation8/20creating some value

Creates more value than its capital costs
Owner earnings growing
Owner earnings per share growing
Reinvests at strong returns
Solid earnings base

What this means

SHL Telemedicine clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryIsrael

IndustryHealth Care Providers & Services

SizeX-Small

TypePublic Company

ExchangeSWX

Founded1986

Employees65

Websiteshl-telemedicine.com

ISINIL0010855885

Last UpdateApr 2, 2026

Indices

SPI (Switzerland)

Themes

Health DiagnosticsMHealthCardiovascularDigital WellnessChronic DiseasesMedicalTelecommunications

Description

SHL Telemedicine Ltd. (SHL) operates as an international group specializing in telemedicine services, including the provision and development of advanced personal telemedicine solutions. The company conducts its operations in Israel, Germany, and the…

Analysis

Middle-of-the-road

SHL Telemedicine Ltd. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is mixed; the safety picture is stretched. The company scores 8/20 on our value-creation score: creating some value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250

2026

All-time high

Jun 2026

All-time low

Mar 2026

Average rank

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023

Price/Sales

—

Price/Earnings

—

Price/Book

—

Dividend Yield

—

Value (overall)

—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare SHL Telemedicine with its peers

Anbio Biotechnology

NMQ:NNNN

—

CountryGermany

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

InMode

NSQ:INMD

CountryIsrael

IndustryHealth Care Equipment & Supplies

SizeSmall

Full Stock Analysis →

Big Technologies

LSE:BIG

CountryUK

IndustryElectronic Equipment, Instruments & Components

SizeSmall

Full Stock Analysis →

NewAmsterdam Pharma Company

NMQ:NAMS

CountryNetherlands

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

Dr Martens

LSE:DOCS

CountryUK

IndustryTextiles, Apparel & Luxury Goods

SizeMedium

Full Stock Analysis →

Kiniksa Pharmaceuticals

NSQ:KNSA

CountryUK

IndustryBiotechnology

SizeMedium

Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View

1 · Watch OutGood· 100

Value

1 · ExpensiveGood Value· 100

Quality

1 · Weak FundamentalsHigh Quality· 100

Growth

1 · Tough TimesHigh Growth· 100

Safety

1 · High LeverageWell-Financed· 100

Sentiment

1 · SkepticismPositive· 100

Learn More →